Rubicon Research files for IPO with SEBI, Targets ₹10,850 Million to drive growth and innovation
Focused on regulated markets, Rubicon Research plans to use proceeds for debt repayment, strategic acquisitions, and corporate…
Author
Clariant and OMV aim to reduce carbon footprint of ethylene and ethylene oxide derivatives
Clariant and OMV sign a letter of intent to accelerate the transition towards renewable carbon in the European ethylene supply…
Fischer Medical Ventures partners with Bio Angle Vacs Sdn Bhd’s in science, technology and marketing
Aim to bring breakthrough vaccine products that substantially reduce Mortality rate of livestock and aquaculture into India
Express Pharma August 2024
India's Foremost Pharma & Biotech Magazine ~ Forging The Path For Tomorrow's Therapeutics
Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide:…
With promising Phase IIa results and a dual GLP-1/GIP receptor mechanism, VK2735 could soon compete directly with tirzepatide in…
FOPE organises workshop on human error reduction at Hyderabad
Regulatory officials as well as industry leaders and experts came together to discuss strategies for minimising errors and…
Lupin secures tentative U.S. FDA approval for generic HIV treatment under PEPFAR
Lupin to manufacture and supply affordable Emtricitabine and Tenofovir Alafenamide tablets from Nagpur facility to low and…
Vector Consulting Group reveals strategies for pharma firms to boost agility and cost efficiency in…
Strategies to increase output by 40-70% in Operations and R&D; Reduce of lab incidents by 50-70%
Zydus receives approval from COFEPRIS of Mexico to market Mamitra
The Mexican regulatory authority has granted marketing approval for a Trastuzumab biosimilar to treat various cancers
NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013
Action is taken against companies found selling formulations at prices higher than the permissible price